Exact Sciences Corporation - Sales Analysis Snapshot

Business Description
This Report provides a comprehensive Sales & Margin summary analysis for Exact Sciences Corporation Tabular results include up to a ten-year history on Sales, EBITDA (Earnings before Interest, Taxes, Depreciation and Amortization), Income before Extraordinary Items and number of Employees. Additional ratios are included for sales growth, earnings and income as a percent of sales and Sales per Employee.

Exact Sciences Corporation. The Group's principal activities are to develop and commercialize proprietary DNA based tests for the early detection of cancer and other types of common cancers. PreGen-Plus utilizes PreGen technologies to isolate the minute amounts of human DNA shed from the colon into stool and then identifies mutations in DNA shed from abnormal cells indicative of colorectal cancer and pre-cancerous lesions. It also offers PreGen-Plus through LabCorp, in the United States with 35 primary laboratories and over 1,600 patient service centers. LabCorp is the exclusive licensee, in the United States and Canada, of the technology that surrounds PreGen-Plus.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report